These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 2104539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D, Lavenu A, Babinet C.
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN, Nakeff A, Mohammad RM, KuKuruga M, al-Katib A.
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K, Schadendorf D.
    Anticancer Res; 1997 Oct; 17(6D):4359-70. PubMed ID: 9494534
    [Abstract] [Full Text] [Related]

  • 10. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
    Gewirtz AM, Shen YM.
    Exp Hematol; 1990 Sep; 18(8):945-52. PubMed ID: 2201557
    [Abstract] [Full Text] [Related]

  • 11. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
    Carbone A, Gusella GL, Radzioch D, Varesio L.
    Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME, Coudray AM, Bréant B, Mester J.
    Cancer Res; 1989 Dec 01; 49(23):6566-71. PubMed ID: 2684395
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modification of proto-oncogene expression by phorbol esters in human dermal microvascular endothelial cells.
    Mansbridge JN, Grymes RA, Karasek MA.
    Cell Mol Biol (Noisy-le-grand); 1992 Nov 01; 38(7):791-8. PubMed ID: 1472905
    [Abstract] [Full Text] [Related]

  • 18. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells.
    Wilding G, Lippman ME, Gelmann EP.
    Cancer Res; 1988 Feb 15; 48(4):802-5. PubMed ID: 3257409
    [Abstract] [Full Text] [Related]

  • 19. Reversible suppression of c-myc expression in a human colon carcinoma line by the anticancer agent N-methylformamide.
    Chatterjee D, Mendelsohn A, Shank PR, Savarese TM.
    Cancer Res; 1989 Jul 15; 49(14):3910-6. PubMed ID: 2660982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.